| Literature DB >> 6605787 |
C L Ehlers, S J Henriksen, M Wang, J Rivier, W Vale, F E Bloom.
Abstract
Corticotropin releasing factor (CRF) is a 41-residue peptide, capable of stimulating the secretion of corticotropin (ACTH)-like and beta-endorphin-like immunoreactivity from the adenohypophysis. Low doses of CRF (0.0015-0.15 nM) given intracerebroventricularly (i.c.v.) produced changes in electrographic activity suggestive of increased arousal. Higher doses of CRF (1.5-3.75 nM) induced, over a period of 3-7 h, electrographic and behavioral signs of seizure activity indistinguishable from those which occur following electrical 'kindling' of the amygdala.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6605787 DOI: 10.1016/0006-8993(83)90266-4
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252